SCHEMBL3979840

SCHEMBL3979840

NC(=O)CSc1c(Cl)cccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
POLB P06746 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
LMNA P02545 4/20 0.43
SOD1 P00441 1/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ADRA2A P08913 2/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTR1A P08908 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
MAOA P21397 1/20 0.42
ADRA1D P25100 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3064663 0.81 FFAR1 (0.54) ALDH1A1SMN1; SMN2LMNASOD1L3MBTL1
SCHEMBL19982393 0.81 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2RAB9APOLBLMNA
SCHEMBL4304293 0.77 SOD1 (0.39) ALDH1A1SMN1; SMN2NPC1RAB9APOLB
SCHEMBL3743740 0.76 KMT2A (0.65) ALDH1A1POLBLMNAHTTL3MBTL1
SCHEMBL11221117 0.75 SMN1; SMN2 (0.47) ALDH1A1SMN1; SMN2NPC1RAB9AHSD17B10
SCHEMBL7420149 0.72 LMNA (0.53) ALDH1A1POLBRXFP1LMNAHTT
SCHEMBL1395735 0.71 SMN1; SMN2 (0.66) ALDH1A1SMN1; SMN2RAB9APOLBLMNA
SCHEMBL11218672 0.71 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL11209836 0.71 MAPT (0.53) ALDH1A1SMN1; SMN2POLBLMNAHSD17B10
SCHEMBL3142048 0.70 KDM4E (0.77) ALDH1A1POLBLMNAHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-12-31 US disclosed
EP-2059305-A2 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE Novartis Ag (CH) 2009-05-20 EP disclosed
WO-2008014307-A2 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE NOVARTIS AG (CH) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE FDPS, UMPS, GGPS1 ALDH1A1 3119/4885SMN1; SMN2 4143/4885NPC1 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.